| Measure | Superluminal Medicines, Inc. | Gossamer Bio, Inc. |
|---|---|---|
| On the record | $65.48M | $25M |
| Industry group | Biotechnology | Biotechnology |
| Filing | Form D | Form D |
| Filed | 2026-09-03 | 2026-09-04 |
| Investors already in | 16 | 38 |
| Non-accredited investors | No | No |
| Entity type | Corporation | Corporation |
| Incorporated in | DELAWARE | DELAWARE |
| Year formed | 2023 | not stated |
| Based | BOSTON, MASSACHUSETTS | San Diego, CALIFORNIA |
| Exemptions claimed | 06b | 06b |
Click a column heading to sort. A cell reading "not stated" means that record does not carry the figure — it is never filled in from the other side, and never guessed.
Superluminal Medicines, Inc.
Against the 5 raises on file in Biotechnology. Median $5.09M, largest $65.48M.
Gossamer Bio, Inc.
Against the 5 raises on file in Biotechnology. Median $5.09M, largest $65.48M.
The full profile
The rest of this profile is open on any paid or trial plan
It costs no credits. It is a plan check and nothing else.
- Source Check — verify what Cony DCruz states, against the registers that hold it.
- INVEST — take this comparison past the two, across the whole group.
- RECRUIT — see who is already on both teams.
- Press Requests — connect with Cony DCruz for a story.
You land back on this comparison when you are in.
Not ready to upgrade? Keep the larger of the two in view instead.
Watchlist Superluminal Medicines, Inc.Both profiles in full: Superluminal Medicines, Inc. · Gossamer Bio, Inc..
Both sides are read from the filing index on sec.gov — Superluminal Medicines, Inc. and Gossamer Bio, Inc.. Figures are read directly from the source record; names have not been matched against other people.